Psychiatry and behavioural health is 5% of our bank, 7 to 8 items on a 150-item paper. Neither the SMLE nor the Qatar DHP blueprint lists psychiatry as a separate top-level area, so where it sits inside their totals is not stated; prep sources describe GP papers in the region as covering it. The items are mostly recognition, first-line choices, drug safety and risk. One fixed number is worth knowing: the lithium therapeutic range of 0.4 to 1.0 mmol/L at 12 hours.
Weight and where it sits
Psychiatry is the smallest of the clinical domains in the bank. A small weight does not mean a small risk: with thirteen subtopics and about 7 to 8 items, a candidate who has not revised it may drop several marks that cost little to win. It also appears indirectly in ethics (capacity, confidentiality, risk) and in emergency medicine (overdose, withdrawal).
What is tested
| Cluster | Subtopics | What the item asks |
|---|---|---|
| Mood and anxiety | Major depressive disorder, bipolar disorder and lithium monitoring, anxiety, panic disorder and OCD, PTSD | Diagnosis from criteria, first-line treatment, monitoring |
| Psychosis | Schizophrenia and antipsychotic adverse effects | Recognition, side-effect management |
| Risk and acute presentations | Suicide risk assessment, substance use and withdrawal, delirium and dementia | Risk, immediate safety, distinguishing delirium from dementia |
| Across the life course | Eating disorders, perinatal mental illness, child and adolescent mental health, ADHD and autism | Recognition and referral, safe prescribing |
| Drugs and presentation | Psychotropic interactions and serotonin syndrome, somatic symptom disorder and culture-sensitive presentations | Interaction recognition, communication |
Guideline points to hold
- Lithium. The therapeutic level is 0.4 to 1.0 mmol/L, measured 12 hours after the dose. Toxicity features tremor, ataxia and confusion. Avoid combining lithium with NSAIDs, ACE inhibitors and thiazides, because they raise the level (NICE bipolar guideline CG185). Monitoring covers the level and, in practice, renal and thyroid function.
- Prescribing. Use international non-proprietary names and avoid brand names.
- Interactions. Serotonin syndrome follows combinations of serotonergic drugs, and the stem usually names two. Learn the recognition features and the first action: stop the agents and give supportive care.
- Safe-writing context. Culture-sensitive presentations are legitimate stem content. Patients may describe psychological distress in physical or spiritual terms, and the right answer respects the framing while still assessing risk. Avoid alcohol-dependent assumptions about the typical patient unless the stem requires them.
Try Gulf GP Exam practice questions free
Create a free account and answer sample questions with full explanations before you buy a pass.
Risk assessment as a sequence
A suicide risk item rewards a sequence, not a label. Ask directly about thoughts, plans and intent. Ask about means, previous attempts and protective factors. Decide the setting: whether the patient can be safely managed in the community, needs urgent specialist review or needs admission. Arrange follow-up and involve family or carers where the patient agrees or where safety requires it. Document the assessment. The wrong answers are usually the ones that skip the direct question, send the patient away with a prescription for a large quantity of a dangerous drug, or promise confidentiality that cannot be kept when life is at risk.
Delirium, dementia and withdrawal
Delirium is acute, fluctuating and marked by inattention. It has a cause to be found, such as infection, drugs, metabolic disturbance or withdrawal, and it is reversible. Dementia is gradual, progressive and not usually fluctuating in the same way. Items ask you to tell them apart and to look for the cause of delirium first. Withdrawal syndromes, especially from alcohol and benzodiazepines, can cause seizures and delirium and need treatment in the right setting. Psychotropic prescribing in older people is a recurring theme: choose the drug with the fewest interactions and the lowest risk for the patient's comorbidities.
Perinatal, child and adolescent presentations
Perinatal mental illness items test recognition and safe prescribing: a mother with low mood or psychosis after birth needs prompt assessment, a risk review that includes the infant, and drug choices that account for pregnancy and breastfeeding. Child and adolescent items cover ADHD and autism, where the point is usually recognition, assessment pathway and the limits of primary care prescribing, and mood or behaviour change in a young person, where risk assessment applies as it does in adults. In each case the best answer involves the right service early, not a prolonged trial in general practice.
Three typical traps
- Diagnosing before assessing risk. When a stem gives low mood and a hint of hopelessness, the first action is a risk assessment and a safety plan, not the choice of antidepressant. Risk comes before drug choice.
- Missing the interaction. Lithium with an NSAID or an ACE inhibitor, or two serotonergic drugs, is the point of the item. Scan the medication list for the second drug before reading the options.
- Treating a culturally framed presentation as purely organic or purely psychiatric. A patient with multiple physical complaints needs a sensible exclusion of organic disease and a respectful, non-dismissive approach. The best answer does both.
How to revise it
- Learn diagnostic criteria as short lists, one card per disorder, then drill them with cases.
- Keep a drug-safety sheet: lithium, antipsychotic adverse effects, serotonin syndrome, and benzodiazepine or alcohol withdrawal.
- Practise risk assessment as a sequence: ask directly, assess intent and means, decide setting, arrange follow-up.
- Cover the life-course topics briefly, noting where the correct answer is referral, not treatment in primary care.
- Do one short mixed set a week through the last month so the domain does not decay.
Place this domain in week 6 of the 8-week plan and week 9 of the 12-week plan in the study plan.
Frequently asked questions
How many psychiatry items will there be?
Our bank gives psychiatry 5%, about 7 to 8 items on a 150-item paper. The SMLE and Qatar DHP blueprints do not list it as a separate top-level area.
What is the lithium therapeutic range?
0.4 to 1.0 mmol/L, measured 12 hours after the dose. Avoid combining with NSAIDs, ACE inhibitors and thiazides.
Do I need to know diagnostic criteria?
Know the key features of each disorder well enough to distinguish them in a short stem, and the first-line approach. The items rarely require reciting full manual criteria.
What is the first step when suicide risk is suspected?
Assess the risk directly, including intent and means, and secure safety before choosing treatment.
Are culture-sensitive presentations tested?
They are listed in our subtopics as legitimate stem content. The best answer respects the patient's framing while assessing risk and excluding organic disease.